Post by UCB

During #ICNMD2026, we will be sharing new data on our targeted generalized myasthenia gravis (#gMG) therapies, including investigations into key patient outcomes and treatment experience. Beyond the data, we’re creating space for dialogue at ICNMD through our symposium at the congress. The discussion will bring together experts to discuss the latest treatment advances, and implications for current clinical practice. #MyastheniaGravis